[go: up one dir, main page]

MX2014001409A - Metodo para tratar esquizofrenia. - Google Patents

Metodo para tratar esquizofrenia.

Info

Publication number
MX2014001409A
MX2014001409A MX2014001409A MX2014001409A MX2014001409A MX 2014001409 A MX2014001409 A MX 2014001409A MX 2014001409 A MX2014001409 A MX 2014001409A MX 2014001409 A MX2014001409 A MX 2014001409A MX 2014001409 A MX2014001409 A MX 2014001409A
Authority
MX
Mexico
Prior art keywords
treating schizophrenia
fatty acid
present
acid derivative
provides
Prior art date
Application number
MX2014001409A
Other languages
English (en)
Other versions
MX359697B (es
Inventor
Ryuji Ueno
Original Assignee
Sucampo Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Sucampo Ag filed Critical Sucampo Ag
Publication of MX2014001409A publication Critical patent/MX2014001409A/es
Publication of MX359697B publication Critical patent/MX359697B/es

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C405/00—Compounds containing a five-membered ring having two side-chains in ortho position to each other, and having oxygen atoms directly attached to the ring in ortho position to one of the side-chains, one side-chain containing, not directly attached to the ring, a carbon atom having three bonds to hetero atoms with at the most one bond to halogen, and the other side-chain having oxygen atoms attached in gamma-position to the ring, e.g. prostaglandins ; Analogues or derivatives thereof
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C59/00—Compounds having carboxyl groups bound to acyclic carbon atoms and containing any of the groups OH, O—metal, —CHO, keto, ether, groups, groups, or groups
    • C07C59/40—Unsaturated compounds
    • C07C59/76—Unsaturated compounds containing keto groups
    • C07C59/88—Unsaturated compounds containing keto groups containing halogen
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/557—Eicosanoids, e.g. leukotrienes or prostaglandins
    • A61K31/5575—Eicosanoids, e.g. leukotrienes or prostaglandins having a cyclopentane, e.g. prostaglandin E2, prostaglandin F2-alpha
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/18—Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C69/00—Esters of carboxylic acids; Esters of carbonic or haloformic acids
    • C07C69/66—Esters of carboxylic acids having esterified carboxylic groups bound to acyclic carbon atoms and having any of the groups OH, O—metal, —CHO, keto, ether, acyloxy, groups, groups, or in the acid moiety
    • C07C69/73—Esters of carboxylic acids having esterified carboxylic groups bound to acyclic carbon atoms and having any of the groups OH, O—metal, —CHO, keto, ether, acyloxy, groups, groups, or in the acid moiety of unsaturated acids
    • C07C69/738—Esters of keto-carboxylic acids or aldehydo-carboxylic acids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K2121/00—Preparations for use in therapy

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Psychiatry (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)

Abstract

La presente Invención proporciona un nuevo derivado de ácido graso; la presente invención también proporciona el uso de una cantidad efectiva de un derivado de ácido graso para tratar esquizofrenia en un sujeto mamífero.
MX2014001409A 2011-08-05 2012-08-03 Metodo para tratar esquizofrenia. MX359697B (es)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US201161515418P 2011-08-05 2011-08-05
PCT/JP2012/070411 WO2013022079A1 (en) 2011-08-05 2012-08-03 Method for treating schizophrenia

Publications (2)

Publication Number Publication Date
MX2014001409A true MX2014001409A (es) 2014-05-28
MX359697B MX359697B (es) 2018-10-08

Family

ID=47627335

Family Applications (1)

Application Number Title Priority Date Filing Date
MX2014001409A MX359697B (es) 2011-08-05 2012-08-03 Metodo para tratar esquizofrenia.

Country Status (18)

Country Link
US (2) US8592483B2 (es)
EP (1) EP2739278A4 (es)
JP (2) JP6193230B2 (es)
KR (1) KR20140076551A (es)
CN (2) CN107903173A (es)
AR (1) AR087468A1 (es)
AU (2) AU2012293157A1 (es)
BR (1) BR112014002712A8 (es)
CA (1) CA2842455A1 (es)
HK (1) HK1252353A1 (es)
IL (2) IL230552A (es)
MX (1) MX359697B (es)
NZ (1) NZ620300A (es)
RU (1) RU2648474C2 (es)
SG (1) SG10201606442QA (es)
TW (2) TWI619498B (es)
WO (1) WO2013022079A1 (es)
ZA (1) ZA201400707B (es)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN103450128B (zh) * 2013-08-15 2015-04-08 河南中帅医药科技股份有限公司 用于治疗青光眼的前列腺素类似物中间体Corey醛的制备方法
US20150057351A1 (en) * 2013-08-22 2015-02-26 Sucampo Ag Method for treating neuropathic pain

Family Cites Families (22)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5225439A (en) 1987-01-28 1993-07-06 K.K. Ueno Seiyaku Oyo Kenkyujo Prostaglandins E and anti ulcers containing same
US5380709A (en) 1987-01-28 1995-01-10 K.K. Ueno Seiyaku Oyo Kenkyujo Prostaglandins E and anti ulcers containing same
CA1322749C (en) * 1987-01-28 1993-10-05 Ryuzo Ueno Prostaglandins of the d series, and tranquilizers and soporifics containing the same
US5166174A (en) 1987-01-28 1992-11-24 K.K. Ueno Seiyaku Oyo Kenkyujo Prostaglandins E and anti-ulcers containing same
US5591887A (en) 1987-04-30 1997-01-07 R-Tech Ueno, Ltd. Prostaglandins of the F series
US5221763A (en) 1987-04-30 1993-06-22 R-Tech Ueno, Ltd. Prostaglandins of the F series
CA1324129C (en) 1987-04-30 1993-11-09 Ryuzo Ueno Prostaglandins of the f series
EP0308135B1 (en) * 1987-09-18 1992-11-19 R-Tech Ueno Ltd. Ocular hypotensive agents
CA2030345C (en) 1989-11-22 1998-12-08 Ryuji Ueno Use of 15-keto-prostaglandin compound for improvement of encephalic function
CA2039420C (en) 1990-04-04 1996-12-10 Ryuji Ueno Treatment of cataract with 15-keto-prostaglandin compounds
CA2150287C (en) 1994-06-03 2004-08-10 Ryuji Ueno Agent for treating hepato-biliary diseases
PT857718E (pt) 1996-06-10 2002-11-29 Sucampo Ag Antagonista da endotelina
TWI225398B (en) * 1999-07-14 2004-12-21 R Tech Ueno Ltd Composition for treatment of external secretion disorders
ITRM20010356A1 (it) * 2001-06-21 2002-12-23 Sigma Tau Ind Farmaceuti "5-alogeno derivati della triptamina utili come ligandi del recettore5-ht6 e/o 5-ht7 della serotonina.
IL157751A0 (en) * 2003-02-28 2004-03-28 Yissum Res Dev Co New amide derivatives of 2,2,3,3-tetramethylcyclopropane carboxylic acid, a method for their synthesis and pharmaceutical compositions containing them
US20040224995A1 (en) * 2003-05-09 2004-11-11 University Of North Texas Health Science Center At Fort Worth Neuroprotective effects of PPARy agonists against cellular oxidative insults
TWI384988B (zh) * 2005-01-27 2013-02-11 Sucampo Ag 處理中樞神經系統失常用之組成物
WO2006093348A2 (en) * 2005-03-04 2006-09-08 Sucampo Ag Method and composition for treating peripheral vascular diseases
US7211703B2 (en) * 2005-04-27 2007-05-01 Calgon Carbon Corporation Method of separating E and Z isomers of an alkene alcohol and derivatives thereof
US20080255203A1 (en) * 2007-04-12 2008-10-16 Abbott Laboratories Heterocyclic compounds and their methods of use
KR101485212B1 (ko) * 2007-07-19 2015-01-22 가부시키가이샤 아루떼꾸 우에노 11-데옥시-프로스타글란딘 화합물을 포함하는 약학 조성물 및 상기 화합물을 안정화시키는 방법
WO2012100347A1 (en) * 2011-01-24 2012-08-02 Inceptum Research & Therapeutics, Inc. Compositions comprising a prostaglandin for treating neuropsychiatric conditions

Also Published As

Publication number Publication date
TWI619498B (zh) 2018-04-01
SG10201606442QA (en) 2016-09-29
JP2017222708A (ja) 2017-12-21
NZ620300A (en) 2015-09-25
TW201316992A (zh) 2013-05-01
KR20140076551A (ko) 2014-06-20
IL230552A (en) 2017-09-28
MX359697B (es) 2018-10-08
AU2017203092B2 (en) 2018-11-08
US20140031428A1 (en) 2014-01-30
BR112014002712A8 (pt) 2017-06-20
US8592483B2 (en) 2013-11-26
HK1252353A1 (zh) 2019-05-24
RU2648474C2 (ru) 2018-03-26
US20130035393A1 (en) 2013-02-07
JP6193230B2 (ja) 2017-09-06
AR087468A1 (es) 2014-03-26
IL230552A0 (en) 2014-03-31
ZA201400707B (en) 2014-11-26
JP2014527048A (ja) 2014-10-09
RU2014108423A (ru) 2015-09-10
IL254289A0 (en) 2017-10-31
CA2842455A1 (en) 2013-02-14
EP2739278A1 (en) 2014-06-11
EP2739278A4 (en) 2015-03-18
TWI619497B (zh) 2018-04-01
CN103841966A (zh) 2014-06-04
WO2013022079A1 (en) 2013-02-14
TW201808302A (zh) 2018-03-16
AU2012293157A1 (en) 2014-03-13
AU2017203092A1 (en) 2017-06-01
BR112014002712A2 (pt) 2017-06-13
CN107903173A (zh) 2018-04-13

Similar Documents

Publication Publication Date Title
SMT201900362T1 (it) Metodo per la riparazione di un legamento o di un tendine
MY166059A (en) Fusion Proteins for Treating Metabolic Disorders
ZA201400005B (en) Method for treating eczema
UY33958A (es) Inhibidores de la glucosilceramida sintasa
UY33930A (es) Inhibidores novedosos de quinasas
IN2014CN04634A (es)
GEP201706626B (en) Synthesis of (s)-nifuratel
SG195111A1 (en) Process for preparing methacrylic acid
EP2758780A4 (en) METHOD OF TREATING MULTIPLE SCLEROSIS
IN2014DN00254A (es)
AU2012245196A8 (en) Fatty acid amide hydrolase inhibitors for treating pain
MX347541B (es) Analogos de acido sialico.
UY34386A (es) Método para la producción de ácido láctico
BR112013023253A2 (pt) método para fabricação de um artigo absorvente
GB201107985D0 (en) Process
MX352071B (es) Ésteres de lactato eterificados, método de producción de los mismos y uso de los mismos para intensificar el efecto de agentes protectores de plantas.
HUE038149T2 (hu) Eljárás acél kezelésére
MX359697B (es) Metodo para tratar esquizofrenia.
EP2675455A4 (en) OPHTHALMIC COMPOSITION FOR DILATING PUPILS
IN2014MN01871A (es)
GB201109838D0 (en) Method for the differentiation of alternative sources of naphthenic acids
IL235612B (en) A method for identifying the species of the twins
MX361673B (es) Procedimiento para la preparación de intermediarios de ácido borónico.
MX361888B (es) Un procedimiento mejorado para producir zilpaterol.
PL2753625T3 (pl) Sposób wytwarzania związków zawierających grupę alfa-oksyfosforową dzięki zastosowaniu aktywatora

Legal Events

Date Code Title Description
FG Grant or registration